Bussiness Ideas

CardioAI Precision is a health-tech venture focused on revolutionizing the way coronary artery disease (CAD) is diagnosed and managed in India and other emerging markets. CAD is the leading cause of death worldwide, and in India, the burden is rising rapidly, especially among younger adults. The gold standard today for assessing coronary blockages is invasive angiography and fractional flow reserve (FFR). These procedures are expensive, risky, and limited to tertiary hospitals, leaving millions of patients in tier-2/3 cities and rural areas without timely access to advanced cardiac diagnostics. Our solution is to leverage artificial intelligence and deep learning to analyze cardiac CT angiography (CTCA) scans, transforming them into a comprehensive diagnostic tool. CardioAI’s platform provides: 3D Coronary Mapping Stenosis Detection: Identifies blockages in the coronary tree. CT-FFR: A non-invasive alternative to wire-based FFR, measuring the physiological impact of lesions. Plaque Characterisation: Detects calcified and non-calcified plaques, including vulnerable plaques often missed in traditional diagnostics. Myocardial Analysis: Adds functional assessment for a complete cardiac picture. Unlike global competitors such as HeartFlow and CathWorks, CardioAI Precision is designed as a hardware-agnostic SaaS platform that integrates seamlessly with existing CT scanners and PACS/RIS systems. This makes the solution both affordable and scalable, tailored for India and the Global South where cost and accessibility are major barriers. Our business model is built around flexible options: pay-per-use for private hospitals, subscription for government hospitals, and revenue-sharing for rural networks. The long-term vision includes integration into national health programs and expansion into international markets such as the Middle East and Africa. By combining cutting-edge AI technology, affordable access models, and India-first clinical validation, CardioAI Precision aims to make world-class cardiac diagnostics as routine as a blood test, ensuring no patient is denied care due to geography or cost.

Show More

Startup Teams

• 1 Apoorv Pankaj (Director)
• 2 Pankaj Kumar (Director)

Incubation Details

Not Incubated